Emotion Regulation Program for Substance Use Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-65
SponsorThe Catholic University of Korea

About this trial

This study examines whether a newly developed eight-session psychosocial treatment program, called the Emotion Regulation Program, can be delivered in real-world hospital settings to people receiving inpatient care for substance use disorders in Korea, and whether it shows early signs of benefit. The program combines motivational interviewing, acceptance and commitment therapy, and group activities, and is delivered twice a week over about four weeks (eight 50-minute sessions). About 20 adults will take part at two psychiatric hospitals.

Participants complete brief questionnaires and a short interview about their craving, motivation to change, difficulties in emotion regulation, self-compassion, depression, and drug use history before the program, immediately before and after each session, within one week after the program ends, and again at 1 month and 3 months after completion. After the program, some participants also join a small group discussion (focus group interview) to share their experience of the program.

Because this is a small, single-group preliminary (pilot) study without a comparison group, its primary purpose is to assess feasibility, that is, whether the program and the assessment approach work well enough, and to obtain preliminary effect and variability estimates to inform the design of a future large-scale randomized controlled trial.

Eligibility criteria

Qualifiers

Adults aged 19 to 65 years who can understand the study purpose and procedures and provide written informed consent

Currently hospitalized (inpatient)

Able to communicate and complete questionnaires in Korean

Physically able to participate in program activities

Disqualifiers

Cognitive impairment that precludes communication

Physical conditions that preclude program participation (e.g., musculoskeletal disorder, severe cardiopulmonary disease)

Acute psychotic symptoms or risk of self-harm or harm to others

At risk of disrupting group activities such that focus group participation is not feasible

Trial design

Treatments tested in this trial

  • Emotion Regulation Program

Treatment groups

20 Participants
are divided into 1 treatment group